Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

The patch effectively promotes hair growth for alopecia areata without pain.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Dutasteride may help reduce brain inflammation and improve cognition.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Baricitinib is effective as a treatment for severe hair loss.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Treating gastrointestinal issues can reduce rosacea flares, and treating rosacea can lower gastrointestinal problems.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

The FDA approved a new Pfizer drug for hair loss in teens.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Apremilast did not work for treating severe alopecia areata.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Dupilumab may help treat alopecia areata, but more research is needed.